SAGE CHEMS FDA Approval ANDA 212025

ANDA 212025

SAGE CHEMS

FDA Drug Application

Application #212025

Application Sponsors

ANDA 212025SAGE CHEMS

Marketing Status

Prescription001

Application Products

001INJECTABLE;SUBCUTANEOUS30MG/3ML (10MG/ML)0APOMORPHINE HYDROCHLORIDEAPOMORPHINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2022-02-23STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

SAGE CHEMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 212025
            [companyName] => SAGE CHEMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"APOMORPHINE HYDROCHLORIDE","activeIngredients":"APOMORPHINE HYDROCHLORIDE","strength":"30MG\/3ML (10MG\/ML)","dosageForm":"INJECTABLE;SUBCUTANEOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"02\/23\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-02-23
        )

)

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.